June 19, 2014

In June’s installment of her Industry Insights column with eyeforpharma, NAI President, Rita Numerof, Ph.D., discusses the variety of initiatives pharmaceutical companies are focusing on to create value added services for drugs and medical devices.

Value Added Services: The Second Wave of Disease Management, published June 19, 2014, highlights the range of approaches being taken by companies in such initiatives to enhance profitability and competitive position.  Rita provides guidance on implementing value added services and programs to capture the value created as a revenue stream.